A0230200
Adenosine
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 58-61-7
Synonym(S): 9-β-D-Ribofuranosyladenine, Adenine riboside, Adenine-9-β-D-ribofuranoside
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | A0230200-50-MG | In Stock | ₹ 16,107.60 |
A0230200 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 16,107.60
GST (18%): ₹ 2,899.368
Total Price: ₹ 19,006.968
grade
pharmaceutical primary standard
description
API family: adenosine
API family
adenosine
manufacturer/tradename
EDQM
mp
234-236 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
InChI
1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-B0228 500mg Medchemexpress, Adenosine CAS:58-61-7 Purity:>98% | -- | ₹ 5,139.75 | ||
Medchemexpress LLC HY-B0228 5g , Adenosine CAS:58-61-7 Purity:>98% | -- | ₹ 9,905.70 | ||
Adenosine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 11,712.40 | ||
Adenosine | -- | ₹ 10,803.35 | ||
Adenosine | -- | ₹ 28,047.58 | ||
9-beta-D-Ribofuranosyl-9H-purin-6-amine | -- | ₹ 267.00 - ₹ 3,382.00 | ||
Adenosine | -- | ₹ 534.00 - ₹ 4,094.00 | ||
58-61-7 | (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | -- | ₹ 356.00 - ₹ 2,670.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Adenosine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Endogenous neurotransmitter at adenosine receptors. Cardioprotective effects may relate to activation of A1 adenosine receptors. The antiplatelet and anti−inflammatory actions of adenosine appear to be mediated via the A2 adenosine receptor. In contrast, adenosine appears to be a pro-inflammatory mediator in asthma and chronic obstructive pulmonary disease (COPD).
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable